Jm. Davison et al., SUBTRACTED, UNIQUE-SEQUENCE, IN-SITU HYBRIDIZATION - EXPERIMENTAL ANDDIAGNOSTIC APPLICATIONS, The American journal of pathology, 153(5), 1998, pp. 1401-1409
Nonrandom chromosomal aberrations, particularly in cancer, identify pa
thogenic biological pathways and, in some cases, have clinical relevan
ce as diagnostic or prognostic markers. Fluorescence and colorimetric
in situ hybridization methods facilitate identification of numerical a
nd structural chromosome abnormalities. We report the development of r
obust, unique-sequence in situ hybridization probes that have several
novel features: 1) they are constructed from multimegabase contigs of
yeast artificial chromosome (YAC) clones; 2) they are in the form of a
dapter-ligated, short-fragment, DNA Libraries that may be amplified by
polymerase chain reaction; and 3) they have had repetitive sequences
(eg, Alu and LINE elements) quantitatively removed by subtractive hybr
idization. These subtracted probes are labeled conveniently, and the f
luorescence or colorimetric detection signals are extremely bright. Mo
reover, they constitute a stable resource that may be amplified throug
h at least four rounds of polymerase chain reaction without diminishin
g signal intensity, We demonstrate applications of subtracted probes f
or the MYC and EWS oncogene regions, including 1) characterization of
a novel EWS-region translocation in Ewing's sarcoma, 2) identification
of chromosomal translocations in paraffin sections, and 3) identifica
tion of chromosomal translocations by conventional bright-field micros
copy.